Updated Date: Mon, 22 Feb 2021 00:00:00 EST
Category: Uncategorized
Perrigo’s generics split is back on the docket, thanks to $1.55B Altaris offer fkansteiner Mon, 03/01/2021 – 09:21
‘Hub-and-spoke’ biotech BridgeBio scores first FDA approval with Alexion castoff esagonowsky Mon, 03/01/2021 – 10:00
AstraZeneca licenses Junshi’s PD-1 in China in a bizarre commercialization deal aliu Mon, 03/01/2021 – 11:04
W.R. Grace lays out $570M for Albemarle unit to bolster pharma portfolio, API manufacturing fkansteiner Mon, 03/01/2021 – […]
J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public bbulik Mon, 03/01/2021 […]
The current pandemic highlights how remote healthcare robots currently being developed at SFU could be beneficial in the […]
Yeovil Hospital emergency department clinical lead Stevan Bruijns believes that a workforce that feels empowered and valued is […]
Flu, is that thing still around?Of course, although to be fair there isn’t much about right now. Neither […]